bmj2021jisc

Publisher

BMJ Publishing Group Limited

Agreement ID bmj2021jisc
Agreement labeling BMJ Publish and Read 2021 Pilot Agreement
Has the agreement been disclosed and published? Yes
URL https://www.jisc.ac.uk/content/
open-access/our-role#collections
Agreement period 01/01/2021 – 12/31/2021
Consortia / Institution Jisc
Country United Kingdom
SIZE

Approximate range of annual corresponding author publications

180
Comments on size/article output Publishing fund pot is based on the current subscribing consortia’s 2018/19 average funded output
COSTS

How do the costs of the agreement relate to previous subscription-only agreements with the publisher?

Cost decrease
Comments on cost development 75% of total consortium fee invested into the publishing fund
FINANCIAL SHIFT

Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?

 

Subscriptions partly converted to OA publishing fees
OA COVERAGE

Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?

Yes
Are fully open access journals covered by the agreement? No
OA LICENSE CC-BY mandatory
ARTICLE TYPES
Original research articles
ACCESS COSTS

What is the approximate share of access related costs of the overall agreement?

20%-50%
Comments on access costs Perm read fee (25%)
ACCESS COVERAGE

Are all read relevant journals covered by the agreement?

Yes
PERPETUAL ACCESS RIGHTS Yes
WORKFLOW ASSESSMENT Too early to assess
OVERALL ASSESSMENT AND COMMENTS Transitions all funded UKHEI output (current participating consortium) to OA, based on 2018/19 average output, to within the publishing fund cap. Agreement meets funder mandates for 2021. This is a pilot agreement for 2021, will a view to review terms for 2022.
Request contact to the licensee contact@esac-initiative.org